Short-term Effects and Safety of an acute increase of intraocular pressure on Corneal Endothelial Cells
Not Applicable
Recruiting
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0002645
- Lead Sponsor
- Dankook Univeristy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with macular edema or macular degeneration who are scheduled to undergo intravitreal bevacizumab injection.
Causes of macular edema: diabetic macular edema, retinal vein occlusion (center, branch), central serous choroidopathy, etc.
Exclusion Criteria
Patients were excluded if they had any ocular disease, previous any intravitreal injection, use of topical eyedrops for lowering IOP, or any ocular surgery history except cataract surgery that had no complication like phacoemulsification and posterior chamber lens implantation (PE&PCL).
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure;Central corneal thickness;Corneal endothelial cell evaluations (coefficient of variation, hexagonality, cell density)
- Secondary Outcome Measures
Name Time Method Ages, Surgical history (Cataract surgery), Presence or absence of diabetes